Business Context and Reporting Period
This Form 8-K is filed by Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) on April 17, 2026. The report addresses a regulatory compliance issue regarding the company's failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the status of the late filing and listing compliance rather than financial performance data.
Material Changes and Listing Status
- Delisting Notice: The company received a notice from NYSE Regulation indicating non-compliance with Section 1007 of the NYSE American Listed Company Manual due to the late filing of the 2025 Form 10-K.
- Cure Period: The company has an initial six-month cure period (April 17, 2026, to October 17, 2026) to file the report and regain compliance. An additional six-month extension may be granted at NYSE's discretion.
- Trading Status: A trading halt on the company's common stock, initiated on April 2, 2026, remains in effect.
- Stock Designation: The stock will continue to trade under the ticker "APUS" but will carry a ".LF" suffix to signify late filing status until compliance is restored.
Management Commentary and Risks
Management attributes the delay to the continued preparation of financial statements for the fourth quarter and fiscal year 2025, as well as the time required for the independent registered public accounting firm to complete audit procedures. The company expects to file the Form 10-K by April 30, 2026, though it explicitly states there can be no assurance this date will be met. The primary risk is potential delisting if the filing is not completed within the cure period or any granted extensions.
Investor Verification Checklist
- Verify the exact date the Form 10-K for the fiscal year ended December 31, 2025, is filed with the SEC.
- Monitor the status of the trading halt on ticker APUS.
- Confirm whether the ".LF" designation is removed from the stock ticker upon filing.
- Review the upcoming Form 10-K for details on the company's financial position, which is currently unavailable in this filing.